OnKure Therapeutics Merges with Reneo Pharmaceuticals and Secures $65M Private Placement

OnKure Therapeutics has successfully finalized its merger with Reneo Pharmaceuticals, accompanied by a simultaneous private placement that raised $65 million. This strategic move is expected to enhance the combined company’s capabilities and resources in the pharmaceutical sector. The merger aims to streamline operations and bolster the development of innovative treatments. The influx of capital from the private placement will further support the merged entity’s growth initiatives and research endeavors, positioning it for future success in the industry.